These genes include Stat3 and Fgg, which are involved in extracellular matrix organization and crystal formation.[25, 32] Taken together, these findings suggest that the active enhancers emerging after Gly treatment play a key role in activating nephrolithiasis‐associated genes. This evidence concerns the gene FGG and nephrolithiasis.